Ginkgo Bioworks Holdings Inc
NYSE:DNA

Watchlist Manager
Ginkgo Bioworks Holdings Inc Logo
Ginkgo Bioworks Holdings Inc
NYSE:DNA
Watchlist
Price: 7.64 USD 5.67% Market Closed
Market Cap: 424.2m USD

Intrinsic Value

DNA's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one DNA stock under the Base Case scenario is 11.24 USD. Compared to the current market price of 7.64 USD, Ginkgo Bioworks Holdings Inc is Undervalued by 32%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

DNA Intrinsic Value
11.24 USD
Undervaluation 32%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Ginkgo Bioworks Holdings Inc

Valuation History Unavailable

Historical valuation for DNA cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about DNA?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Ginkgo Bioworks Holdings Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Ginkgo Bioworks Holdings Inc

Current Assets 564.5m
Cash & Short-Term Investments 516.9m
Receivables 27.2m
Other Current Assets 20.4m
Non-Current Assets 728.9m
Long-Term Investments 32.2m
PP&E 581.2m
Intangibles 68.8m
Other Non-Current Assets 46.8m
Efficiency

Free Cash Flow Analysis
Ginkgo Bioworks Holdings Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Ginkgo Bioworks Holdings Inc

Revenue
237.4m USD
Cost of Revenue
-47.4m USD
Gross Profit
190m USD
Operating Expenses
-582.3m USD
Operating Income
-392.3m USD
Other Expenses
-79.8m USD
Net Income
-472.1m USD
Fundamental Scores

DNA Profitability Score
Profitability Due Diligence

Ginkgo Bioworks Holdings Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

24/100
Profitability
Score

Ginkgo Bioworks Holdings Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

DNA Solvency Score
Solvency Due Diligence

Ginkgo Bioworks Holdings Inc's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Low Altman Z-Score
45/100
Solvency
Score

Ginkgo Bioworks Holdings Inc's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

DNA Price Targets Summary
Ginkgo Bioworks Holdings Inc

Wall Street analysts forecast DNA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DNA is 8.36 USD with a low forecast of 5.05 USD and a high forecast of 12.6 USD.

Lowest
Price Target
5.05 USD
34% Downside
Average
Price Target
8.36 USD
9% Upside
Highest
Price Target
12.6 USD
65% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Ginkgo Bioworks Holdings Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for DNA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

DNA Insider Trading
Buy and sell transactions by insiders

DNA News

Other Videos
What is the Intrinsic Value of one DNA stock?

The intrinsic value of one DNA stock under the Base Case scenario is 11.24 USD.

Is DNA stock undervalued or overvalued?

Compared to the current market price of 7.64 USD, Ginkgo Bioworks Holdings Inc is Undervalued by 32%.

Back to Top